Epigenetic Mechanisms in Autoimmune Thyroid Diseases: Bridging Research and Clinical Applications
International Journal of Molecular Sciences · 07.12.2025 · 26 (24) · 11823
DOI: 10.3390/ijms262411823 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.12.2025. Verfasst von Shouxia Xiao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi Medical University, Zunyi 563000, China. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Hashimoto Disease, Autoimmune Diseases, Thyroid Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Autoimmune thyroid disease (AITD) exemplifies an organ-specific autoimmune disorder, including Hashimoto’s thyroiditis (HT) and Graves’ disease (GD). HT is characterized by hypothyroidism, whereas GD primarily presents as hyperthyroidism. Immunological evidence indicates that AITD pathogenesis requires both a permissive genetic background and environmental triggers to initiate and sustain disease progression. However, the exact molecular and cellular pathways through which these elements synergize to trigger and sustain autoimmune responses remain unclear. Emerging evidence suggests that epigenetic regulation serves as the key interface decoding genetic predisposition through environmental stimuli in AITD etiology. Studies show that environmental epigenetic reprogramming initiates AITD development in genetically susceptible individuals. Epigenetic regulators, including DNA methylation, histone modifications, and non-coding RNA activity, finely tune transcriptional outputs to influence disease trajectories. Beyond elucidating AITD pathogenesis, these epigenetic alterations offer clinical value as diagnostic biomarkers and modifiable therapeutic targets, facilitating precision medicine approaches from early detection to customized interventions. These epigenetic modifications not only elucidate AITD pathophysiology but also provide measurable markers for early diagnosis and molecular targets for personalized treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology, Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi Medical University, Zunyi 563000, China.
- School of Basic Medical Sciences, Key Laboratory of Cancer Prevention and Treatment of Guizhou Province, Zunyi Medical University, Zunyi 563000, China.
ORCID-Profile: Hongsong Yu
Zitieren
APA
Xiao, S., Hu, Y., Wang, X., & Yu, H. (2025). Epigenetic Mechanisms in Autoimmune Thyroid Diseases: Bridging Research and Clinical Applications. International Journal of Molecular Sciences, 26(24), 11823. https://doi.org/10.3390/ijms262411823
Vancouver
Xiao S, Hu Y, Wang X, Yu H. Epigenetic Mechanisms in Autoimmune Thyroid Diseases: Bridging Research and Clinical Applications. International Journal of Molecular Sciences. 2025;26(24):11823. doi:10.3390/ijms262411823
BibTeX
@article{Xiao2025,
author = {Xiao, Shouxia and Hu, Yuelin and Wang, Xin and Yu, Hongsong},
title = {Epigenetic Mechanisms in Autoimmune Thyroid Diseases: Bridging Research and Clinical Applications},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {24},
pages = {11823},
doi = {10.3390/ijms262411823}
}
EUVIMED